Comprehensive analysis of anoikis-related gene signature in ulcerative colitis using machine learning algorithms

被引:0
作者
Liu, Peng [1 ]
Sun, Chunyan [1 ]
Wang, Xiaojuan [2 ]
Han, Bing [2 ]
Sun, Yuhao [1 ]
Liu, Yanbing [1 ]
Zeng, Xin [1 ]
机构
[1] Tongji Univ, Shanghai East Hosp, Dept Gastroenterol, Sch Med, Shanghai, Peoples R China
[2] Fudan Univ, Minhang Hosp, Dept Pharm, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
ulcerative colitis; anoikis; diagnostic marker; machine learning algorithm; immune cells; COMPLEMENT FACTOR-B; MAINTENANCE THERAPY; RESISTANCE; INDUCTION; CELLS; ACTIVATION; INFLIXIMAB; EXPRESSION; HALLMARK; RECEPTOR;
D O I
10.3389/fmed.2025.1498864
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with an idiopathic origin, characterized by persistent mucosal inflammation. Anoikis is a programmed cell death mechanism activated during carcinogenesis to eliminate undetected isolated cells from the extracellular matrix. Although existing evidence indicates that anoikis contributes to the modulation of immune response, the involvement of anoikis-related genes (ARGs) in UC pathogenesis and their interaction with infiltrating immune cells has not been thoroughly explored. The GSE75214, GSE92415, and GSE16879 datasets were acquired and integrated from the GEO database. Additionally, 58 ARGs were identified through the GSEA database. Key anoikis-DEGs in UC were identified using three machine learning algorithms, including least absolute shrinkage and selection operator (LASSO) Cox regression, random forest (RF), and support vector machine (SVM). Receiver operating characteristic (ROC) analysis was utilized to evaluate the diagnostic accuracy of each gene. Subsequently, Single sample GSEA (ssGSEA) was executed to explore the relationships within immune cell infiltration, UC subtypes, and key anoikis-DEGs. Besides, unsupervised cluster analysis was conducted to categorize the UC samples into distinct subgroups, followed by comparing subtype differences. Finally, the upstream regulatory network was constructed and visualized. A comprehensive analysis of the involvement of ARGs in UC was performed, revealing their expression profile, correlation with infiltrating immune cells, and enrichment analyses. We identified five key anoikis-DEGs (PDK4, CEACAM6, CFB, CX3CL1, and HLA-DMA) and demonstrated their high diagnostic accuracy for UC. Moreover, CEACAM6, CFB, CX3CL1, and HLA-DMA exhibited positive associations with infiltrating immune cells in UC, whereas PDK4 displayed a negative correlation with all immune cells. Unsupervised cluster analysis enabled the classification of UC patients into two clusters, both of which exhibited distinct gene expression profiles and immune signaling pathways. Further, based upon the upstream regulatory network, TP53, RARB, RXRB, and CTCF potentially exerted regulatory functions. Our analysis identified five key anoikis-DEGs as characteristic biomarkers of UC. These genes were strongly associated with the infiltration of both innate and adaptive immune cells, as well as immune pathways. This study highlights the role of anoikis genes in UC pathophysiology and offers valuable insights for further elucidating UC pathogenesis and individualized therapy.
引用
收藏
页数:19
相关论文
共 55 条
[1]   Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming [J].
Adeshakin, Funmilayo O. ;
Adeshakin, Adeleye O. ;
Afolabi, Lukman O. ;
Yan, Dehong ;
Zhang, Guizhong ;
Wan, Xiaochun .
FRONTIERS IN ONCOLOGY, 2021, 11
[2]   Endosomes: Emerging Platforms for Integrin-Mediated FAK Signalling [J].
Alanko, Jonna ;
Ivaska, Johanna .
TRENDS IN CELL BIOLOGY, 2016, 26 (06) :391-398
[3]   CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease [J].
Barnich, Nicolas ;
Carvalho, Frederic A. ;
Glasser, Anne-Lise ;
Darcha, Claude ;
Jantscheff, Peter ;
Allez, Matthieu ;
Peeters, Harald ;
Bommelaer, Gilles ;
Desreumaux, Pierre ;
Colombel, Jean-Frederic ;
Darfeuille-Michaud, Arlette .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (06) :1566-1574
[4]   Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment [J].
Bisgaard, Tania H. ;
Allin, Kristine H. ;
Keefer, Laurie ;
Ananthakrishnan, Ashwin N. ;
Jess, Tine .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (11) :717-726
[5]   Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning [J].
Brugnara, Gianluca ;
Neuberger, Ulf ;
Mahmutoglu, Mustafa A. ;
Foltyn, Martha ;
Herweh, Christian ;
Nagel, Simon ;
Schonenberger, Silvia ;
Heiland, Sabine ;
Ulfert, Christian ;
Ringleb, Peter Arthur ;
Bendszus, Martin ;
Mohlenbruch, Markus A. ;
Pfaff, Johannes A. R. ;
Vollmuth, Philipp .
STROKE, 2020, 51 (12) :3541-3551
[6]   Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration [J].
Buchheit, C. L. ;
Angarola, B. L. ;
Steiner, A. ;
Weigel, K. J. ;
Schafer, Z. T. .
CELL DEATH AND DIFFERENTIATION, 2015, 22 (08) :1275-1286
[7]   Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM [J].
Carvalho, Frederic A. ;
Barnich, Nicolas ;
Sivignon, Adeline ;
Darcha, Claude ;
Chan, Carlos H. F. ;
Stanners, Clifford P. ;
Darfeuille-Michaud, Arlette .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (10) :2179-2189
[8]   A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration [J].
Chi, Hao ;
Jiang, Puyu ;
Xu, Ke ;
Zhao, Yue ;
Song, Bingyu ;
Peng, Gaoge ;
He, Bingsheng ;
Liu, Xin ;
Xia, Zhijia ;
Tian, Gang .
FRONTIERS IN GENETICS, 2022, 13
[9]   A State-of-the-Art Review of New and Emerging Therapies for the Treatment of IBD [J].
Chudy-Onwugaje, Kenechukwu O. ;
Christian, Kaci E. ;
Farraye, Francis A. ;
Cross, Raymond K. .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (05) :820-830
[10]   Identification of a novel anoikis-related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma [J].
Diao, Xiayao ;
Guo, Chao ;
Li, Shanqing .
THORACIC CANCER, 2023, 14 (03) :320-330